These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT. Lee HJ; Gulbis A; De Padua Silva L; Hosing C; Khouri I; de Lima M; Champlin RE; Ciurea SO Bone Marrow Transplant; 2008 Jul; 42(1):67-9. PubMed ID: 18347568 [No Abstract] [Full Text] [Related]
5. Guillain-Barré syndrome after rituximab in a patient with idiopathic thombocytopenic purpura: a causal association? Jaso R; Sierra M; Calleja J; Valero C; Pascual J J Neurol; 2010 Mar; 257(3):488-9. PubMed ID: 20229293 [No Abstract] [Full Text] [Related]
7. Successful control of steroid-intolerant Evans' syndrome associated with allogeneic peripheral blood hematopoietic stem cell transplant by rituximab. Ryeon Lee S; Lee SY; Nam MH; Park Y; Jong Park S; Jung Sung H; Won Choi C; Soo Kim B Leuk Lymphoma; 2011 Mar; 52(3):528-30. PubMed ID: 21275632 [No Abstract] [Full Text] [Related]
8. [Treatment outcome of hematopoietic stem cell transplantation for malignant lymphoma]. Tanosaki R Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1322-30. PubMed ID: 16097587 [No Abstract] [Full Text] [Related]
9. Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation. Coppoletta S; Tedone E; Galano B; Soracco M; Raiola AM; Lamparelli T; Gualandi F; Bregante S; Ibatici A; di Grazia C; Dominietto A; Varaldo R; Bruno B; Frassoni F; Van Lint MT; Bacigalupo A Biol Blood Marrow Transplant; 2011 Jun; 17(6):901-7. PubMed ID: 20950702 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. Patriarca F; Medeot M; Isola M; Battista ML; Sperotto A; Pipan C; Toffoletti E; Dozzo M; Michelutti A; Gregoraci G; Geromin A; Cerno M; Savignano C; Rinaldi C; Barbone F; Fanin R Transpl Infect Dis; 2013 Jun; 15(3):259-67. PubMed ID: 23405972 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to treat graft-versus-host disease. Carella AM; D'Arena G; Cascavilla N Mini Rev Med Chem; 2011 Jun; 11(6):473-9. PubMed ID: 21561410 [TBL] [Abstract][Full Text] [Related]
12. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. van Esser JW; Niesters HG; van der Holt B; Meijer E; Osterhaus AD; Gratama JW; Verdonck LF; Löwenberg B; Cornelissen JJ Blood; 2002 Jun; 99(12):4364-9. PubMed ID: 12036863 [TBL] [Abstract][Full Text] [Related]
13. [The clinical safety and efficacy of low dose rituximab regimen on patients with Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation]. Ai H; Fu YW; Wang Q; Liu XC; Wei XD; Song YP Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):592-595. PubMed ID: 30060332 [TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome after human herpesvirus-6 reactivation in unrelated hematopoietic stem cell transplantation. Piras E; Caocci G; Pisano V; Orrù F; Murgia F; Sanna M; Vacca A; La Nasa G Leuk Lymphoma; 2013 Jun; 54(6):1332-3. PubMed ID: 23088724 [No Abstract] [Full Text] [Related]
16. Rituximab treatment may disturb the normal pattern of lymphopoiesis after cord blood SCT. Barba P; Garcia-Cadenas I; Nomdedéu J; Martino R; Gallur L; Valcárcel D Bone Marrow Transplant; 2012 Mar; 47(3):458-60. PubMed ID: 21552304 [No Abstract] [Full Text] [Related]
17. Long-term results of rituximab treatment for membranous nephropathy after allogeneic hematopoietic SCT: a case report. Mattei D; Sorasio R; Guarnieri A; Marazzi F; Formica M; Fortunato M; Mordini N; Rapezzi D; Gallamini A Bone Marrow Transplant; 2010 Jun; 45(6):1111-2. PubMed ID: 19784075 [No Abstract] [Full Text] [Related]
18. [Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation: a case report and literature review]. Shi YJ; Han Y; Wang Y; Zhou R; Song R; Mao DF; Xi R; Bai H; Wu T Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):509-511. PubMed ID: 38964928 [TBL] [Abstract][Full Text] [Related]
19. Molecular monitoring and stepwise preemptive therapy for Epstein-Barr virus viremia after allogeneic stem cell transplantation. Liu Q; Xuan L; Liu H; Huang F; Zhou H; Fan Z; Zhao K; Wu M; Xu L; Zhai X; Zhang F; Liu C; Sun J; Huang X Am J Hematol; 2013 Jul; 88(7):550-5. PubMed ID: 23564232 [TBL] [Abstract][Full Text] [Related]
20. Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report. Vischini G; Cudillo L; Ferrannini M; Di Daniele N; Cerretti R; Arcese W J Nephrol; 2009; 22(1):160-3. PubMed ID: 19229832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]